James Kuo


Adeona Pharmaceuticals pulls in $1M equity investment

Adeona Pharmaceuticals (AMEX: AEN) has received a $1 million equity investment from a Florida private equity firm as the drug developer looks to bring a drug to market for the first time. The funding comes from the sale of 1.2 million shares to Seaside 88 LP, according to a statement from Adeona. Any source of […]


Q&A with Adeona Pharmaceuticals’ new chief executive

The last couple years have been a bumpy ride for Adeona Pharmaceuticals. The company nearly collapsed in the wake of an FDA rejection of its top drug candidate, Coprexa, in January 2008, and Adeona has had four different chief executives in the last 12 months. Perhaps seeking a divorce from the bad memories, the company […]